Open-Label Phase III Trial of Panitumumab Plus Best Supportive Care Compared With Best Supportive Care Alone in Patients With Chemotherapy-Refractory Metastatic Colorectal Cancer - Concepedia

Concepedia

Publication | Closed Access

Open-Label Phase III Trial of Panitumumab Plus Best Supportive Care Compared With Best Supportive Care Alone in Patients With Chemotherapy-Refractory Metastatic Colorectal Cancer

2K

Citations

28

References

2007

Year

Eric Van Cutsem, Marc Peeters, Salvatore Siena, Yves Humblet, Alain Hendlisz, Bart Neyns, Jean-Luc Canon, Jean–Luc Van Laethem, Joan Maurel, Gary Richardson,

Journal of Clinical Oncology

Abstract

Panitumumab significantly improved PFS with manageable toxicity in patients with chemorefractory colorectal cancer.

References

	Year	Citations

Page 1